Sign in

CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
204580525
Phone
646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 424B7 Offering Prospectus
  7. 8-K Event Regulation FD disclosure · Other events
  8. DEFA14A Proxy Proxy Materials
  9. ARS Other Annual Report to Security Holders
  10. DEF 14A Proxy Proxy Statement
  11. 4 Insider Changes in Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Insider Changes in Ownership
  14. 4/A Insider Changes in Ownership
  15. 4/A Insider Changes in Ownership
  16. 4/A Insider Changes in Ownership
  17. 4/A Insider Changes in Ownership
  18. 144 Insider Sale of Securities
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 6 of 41 · 811 filings